Amid backlash, Novo Nordisk reports positive cardiovascular profile for Wegovy

Wegovy has been approved in the US and Europe for weight loss management in patients aged 12 years and older.

Aug 8, 2023 - 20:00

Wegovy has been approved in the US and Europe for weight loss management in patients aged 12 years and older.

Read the original article

Tags:

Previous Article

Arcus and Gilead terminate development for etrumadenant in prostate cancer

Jacobio Pharma receives breakthrough therapy designation for glecirasib

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

STAT+: More hospital and outpatient visits expected to persist through fall and winter

STAT+: More hospital and outpatient visits expected to ...

Oct 2, 2023

STAT+: Drugs are still mostly tested in white men. Will the FDA change that next year?

STAT+: Drugs are still mostly tested in white men. Will...

Dec 21, 2023